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Abstract
Regulative circuits controlling expression of genes involved in the same biological processes are frequently interconnected.
These circuits operate to coordinate the expression of multiple genes and also to compensate dysfunctions in specific
elements of the network. Caspases are cysteine-proteases with key roles in the execution phase of apoptosis. Silencing of
caspase-2 expression in cultured glioblastoma cells allows the up-regulation of a limited number of genes, among which
some are related to cholesterol homeostasis. Lysosomal Acid Lipase A (LIPA) was up-regulated in two different cell lines in
response to caspase-2 down-regulation and cells silenced for caspase-2 exhibit reduced cholesterol staining in the lipid
droplets. We expanded this observation by large-scale analysis of mRNA expression. All caspases were analyzed in terms of
co-expression in comparison with 166 genes involved in cholesterol homeostasis. In the brain, hierarchical clustering has
revealed that the expression of regulative apoptotic caspases (CASP2, CASP8 CASP9, CASP10) and of the inflammatory
CASP1 is linked to several genes involved in cholesterol homeostasis. These correlations resulted in altered GBM
(Glioblastoma Multiforme), in particular for CASP1. We have also demonstrated that these correlations are tissue specific
being reduced (CASP9 and CASP10) or different (CASP2) in the liver. For some caspases (CASP1, CASP6 and CASP7) these
correlations could be related to brain aging.
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Introduction
Caspases were initially discovered as critical enzymes in the
control of apoptosis. Quite soon it was evident that, they can
supervise additional biological processes, such as inflammation
and differentiation [1,2]. This discovery has granted the dichot-
omy between apoptotic and non-apoptotic caspases. More
recently, it has been observed that caspases controlling apoptosis
can also play specific roles unrelated to cell death [3–5].
Caspases can be divided into initiator and effector caspases
depending on the presence of a long prodomain at their amino-
terminal region. Initiator caspases act at the apex of a proteolytic
cascade, whereas effector caspases act downstream and are
involved in the cleavage of specific cellular proteins [1].
Caspase-2, caspase-8, caspase-9, and caspase-10 are the long
prodomain caspases involved in the apoptotic process. Caspase-8
and caspase-10 have well-established roles in the engagement of
the extrinsic pathway, whereas caspase-9 is the critical enzyme for
the intrinsic/mitochondrial pathway. Caspase-8 can also play roles
unrelated to apoptosis, such as in NF-kB activation or in limiting
necroptosis and caspase-10 has been recently shown to control
autophagy [6].
Caspase-2 is still a mysterious caspase. It shows a peculiar
nuclear localization that is regulated by two different NLSs [7]. A
CARD domain, at the amino-terminal region is responsible for the
homotypic interaction with adaptor molecules. Although a
molecular platform controlling its activation has been described
[8,9], the contribution of caspase-2 to apoptosis is still debated.
Different, sometimes controversial results have been published and
multiple functions have been attributed to caspase-2.
Mice deficient for caspase-2 and for its adaptor protein RAIDD
have proved absent or only very limited defects in apoptosis [8,9].
Further studies with cells from caspase-2 2/2 mice have
indicated that caspase-2 could be considered a tumor suppressor,
since its absence can favor oncogene-mediated transformation
[10,11].
Difficulties in defining a gene function in specific biological
context could arise from the presence of regulative circuits that
compensate the experimental alteration. There are several
examples of genes down-regulated by siRNA approaches, or
through homologous recombination in mice, which have gener-
ated only minimal phenotypes [12–14].
The still obscure impact of caspase-2 on cell functions could be
masked by compensatory mechanisms engaged following its
inactivation. In this manuscript we have investigated the gene
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expression profile of human cells silenced for caspase-2 expression.
Our goal was to unveil whether perturbation of caspase-2 levels
could influence the expression of genes involved in specific cellular
functions, either as part of common regulative circuits or of
compensatory mechanisms.
Materials and Methods
Cell culture, siRNA, reagents and antibodies
U87MG and IMR90-E1A cells were grown in DMEM
supplemented with 10% FBS, penicillin (100 U/mL), glutamine
(2 mmol/L), and streptomycin (100 mg/mL) at 37uC in 5% CO2
atmosphere. RNA oligos for interference (RNAi) were purchased
from Dharmacon: CASP2 RNAi1, AAACAGCUGUUGUU-
GAGCGAA; Control1 (CASP2 mutated) RNAi, AAACAAUU-
GUUGUUGAGCGAA; or Qiagen: CASP2 RNAi2 CAUCUU-
CUGGAGAAGGACATT and a non-targeting siRNA UUCU-
CCGAACGUGUCACGU, Control2. Cells were transfected
24 hours after plating by adding the Opti-MEM medium
containing Lipofectamine 2000 (Invitrogen) plus RNAi oligos.
BSA and Filipin (Sigma), anti-LBPA [15], anti-transferrin receptor
(Tnf-R) (OKT9), anti-GM-130 (BD biosciences), anti-caspase-2
[16]. Secondary anti-mouse and anti-rabbit antibodies were Alexa
Fluor 488 and Alexa Fluor 546 conjugated (Invitrogen).
Western blotting
Proteins obtained after an SDS denaturating lysis and
sonication were transferred to a 0.2-mm-pore-sized nitrocellulose
membrane and incubated with the specific primary antibodies.
After several washes, blots were incubated with peroxidase-
conjugated goat anti-rabbit or (Euroclone Milano I) for 1 h at
room temperature. Finally, blots were developed with Super
Signal West Dura, as recommended by the vendor (Pierce).
RNA expression array and data analysis
Total RNA was isolated using RNeasy Mini kit (Qiagen). RNA
sample was labeled according to the standard one cycle
amplification and labeling protocol (Affymetrix). Labeled cRNA
was hybridized on Affymetrix GeneChip Human Gene 1.0 ST
Array. Robust Multi-Array Average (RMA) normalization was
applied [17]. Data analysis was performed using the t-test as
implemented in the R statistical package. A minimum standard
deviation was assumed corresponding to the median percentile of
all standard deviations in order to avoid fortuitously large t
statistics. Differentially expressed genes were selected based on.
1.5 fold change and P,0.05. The analysis of Gene Ontology terms
was performed using the DAVID server [18,19]. Microarray data
have been deposited in NCBI Gene Expression Omnibus (GEO)
and the GEO accession number is GSE61388.
RNA extraction and quantitative qRT-PCR (quantitative
reverse transcription polymerase chain reaction)
Cells were lysed using Tri-Reagent (Molecular Research
Center). A total of 1mg of total RNA was retrotranscribed by
using 100 U of Moloney murine leukemia virus reverse transcrip-
tase (Invitrogen). Quantitative reverse transcription-PCR (qRT-
PCR) analyses were performed using Bio-Rad CFX96 and SYBR
Green technology. The data were analyzed by use of a
comparative threshold cycle using HPRT (hypoxanthine phos-
phoribosyltransferase) and b-actin as normalizer genes. All
reactions were done in triplicate.
Immunofluorescence microscopy
Cells were fixed with 3% paraformaldehyde and permeabilized
with 0.5% Triton X-100 and blocked in PBS 3% BSA for 1 h RT.
After washes coverslips were incubated with Filipin (100mg/mL)
and relative primary antibodies for 2 hrs. After several washes
coverslips were incubated with secondary antibodies. Cells were
imaged with a Leica confocal scanner SP equipped with a 488 l
Ar laser and a 543 to 633 l HeNe laser. Cell images for
deconvolution were taken using the Leica AF6000 LX microscope.
Data preparation and analysis
29 human microarray datasets were included in this study,
totaling 726 arrays. Brain (11 datasets 293 microarrays) GBM (13
datasets 327 microarray) Liver (5 datasets 106 microarrays) were
used and in all cases. All datasets were downloaded manually from
GEO [20] and ArrayExpress databases [21]. We analyzed only
expression data obtained using the most comprehensive human
expression platform HG U133 Plus 2.0. For GBM (GSE11100;
GSE13041; GSE15824; GSE19728; GSE23806; GSE23935;
GSE29796; GSE30563; GSE32374; GSE4290; GSE7696;
GSE9171) for normal human brain (GSE5281; GSE7307;
GSE17612; GSE21935; GSE15824; E-MEXP-2351; GSE21354;
E-MEXP-2280; GSE15209; GSE7692; GSE4290) for human liver
(E-GEOD-40873; E-MTAB-950; E-GEOD-23343; E-AFMX-11;
E-MEXP-2128). We processed all the CEL files together by using
standard tools available within the affy package in R [22].
We use a UniGene ID centered CDF (Chip Description file) in
order to have only one intensity value per gene. CDFs were
downloaded from the Molecular and Behavioral Neuroscience
Institute Microarray Lab (URL:http://brainarray.mbni.med.umich.
edu/Brainarray/Database/CustomCDF/genomic_curated_CDF.
asp) [23]. All annotation information were downloaded from the same
website. The normalization step was done with the standard MAS5.0
algorithm, described in the Statistical Algorithms Description Docu-
ment available from Affymetrix (URL: http://www.affymetrix.com/
support/technical/whitepapers/sadd_whitepaper.pdf).
We converted all microarray data to log values. We extracted
the data regarding the genes of interest in an automatic way.
Correlations among gene expression levels were calculated using
the library psych in R choosing the Pearson correlation method. p-
values were adjusted for multiple testing using Benjamini and
Hochberg’s method [24]. Genes were clustered using hierarchical
clustering using the complete linkage method according to
similarity in correlation patterns, as measured by euclidean
distance [25]. Heat maps were generated with R with positive
correlation scores (values) colored by blue while negative ones
colored by dark green. GO (Gene Ontology) annotations and
knowledge from the literature was used to create a list of genes
involved with the cholesterol metabolism. Gene expression levels
were correlated with age using the Spearman’s correlation making
minimal assumptions about the relationship between the two
diverse variables.
Results and Discussion
Gene expression profile studies in cells with down-
regulated caspase-2 expression
To identify genes and pathways under the influence of caspase-2
we silenced its expression in the glioblastoma cell line U87MG.
We selected glioblastoma cells since important apoptotic functions
have been attributed to caspase-2 in the brain and because CASP2
deficits elicit compensatory mechanisms in this tissue [26,27].
Caspase-2 deficient cells did not display overt alterations in
terms of cell proliferation, cell cycle and apoptosis (data not
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shown). Next transcriptional expression profiles of cells transfected
with caspase-2 siRNA and control siRNA were compared. We
selected a 1.5 fold cut-off and globally 24 genes were significantly
down-regulated (Table S1), whereas 17 genes were significantly
up-regulated in caspase-2 silenced cells (Fig. 1A). This number is
particularly small, since in parallel experiments after silencing of
other genes, such as USP34 or PGAM5 fluctuations in the
expression of more than 200 and 800 genes, respectively were
observed (data not shown). Microarray and immunoblot analysis
proved the effective down-regulation of CASP2 mRNA (Fig. 1A)
and protein (Fig. 1B).
Figure 1. Transcriptomic variations in cells silenced for caspase-2. A. List of the top up-regulated genes (cut-off 1.5) in U87MG cells silenced
for caspase-2 expression. B. Cellular lysates from U87MG cells transfected with the indicated siRNAs against caspase-2 or the relative control siRNAs
were generated and after immunoblot were probed with an anti-caspase-2 antibody. P62, nucleoporin was used as loading control. C. mRNA
expression levels of CYP1B1, CYP51A1 and LIPA were measured using qRT-PCR in U87MG cells transfected with the indicated siRNAs against caspase-
2 or the relative control siRNAs. Data are presented as mean 6 SD; n=3. D. mRNA expression levels of CYP1B1, CYP51A1 and LIPA were measured
using qRT-PCR in IMR90-E1A cells transfected with siRNA1 against caspase-2 or the control siRNA. Data are presented as mean 6 SD; n= 3.
doi:10.1371/journal.pone.0110610.g001
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Next we focused our attention on the 17 genes up-regulated
after caspase-2 down-regulation, which could be entangled in
compensatory responses. Analysis of associated GO terms
indicated that these genes are involved in different biological
functions, including cell cycle control, inflammation and mem-
brane trafficking. Particularly, 3 of them: CYP51A1, CYP1B1 and
LIPA are linked to cholesterol metabolism. Since caspase-2
expression can be influenced by SREBPs and a previous study
proposed a role of caspase-2 in the control of cholesterol and
triacylgycerol levels [28,29], we investigated in more detail the
relationships between caspase-2 and cholesterol genes.
CYP51A1 and CYP1B1 are cytochrome P450 family members
involved respectively in cholesterol/sterol biosynthetic processes
and in the metabolism of a wide range of structurally diverse
substrates, including cholesterol [30,31]. LIPA encodes for the key
enzyme responsible for acidic hydrolysis of cholesteryl esters and
triglycerides delivered from lipoproteins to lysosomes [32].
Furthermore also PIK3R3 (phosphatidylinositol-3 kinase regu-
latory subunit p55c), LCN1 (tears lipocalin), other two caspase-2
influenced genes are in some relations with cholesterol and lipid
metabolism. The first is a target of SREBPs [33] and the second
can bind an assortment of lipids including cholesterol [34]. For all
these reasons we decided to study the relationships between
caspase-2 and CYP51A1, CYP1B1 and LIPA.
qRT-PCR analysis was performed to validate the microarray
experiments. The expression of CYP1B1 and LIPA was
augmented in U87MG cells silenced for caspase-2, whereas for
CYP51A1 the increase was minimal and not statistically significant
(Fig. 1C). To confirm these results we used a second siRNA
against caspase-2 (siRNA2) and a second control oligos, from a
different provider (Fig. 1B). The results were similar. CYP1B1 and
LIPA expression was augment in U87MG cells silenced for
caspase-2. We also investigated whether this up-regulation could
be observed in other cell lines. Figure 1D shows that only LIPA
induction can be observed in human fibroblasts expressing the
E1A oncogene after caspase-2 silencing. In this cell line CYP51A1
and CYP1B1 mRNA levels resulted unchanged. However LIPA
up-regulation was much more pronounced compared to U87MG
cells. These findings indicate that correlations between caspase-2
and cholesterol genes expression could vary in different cell types.
Figure 2. Cholesterol distribution in cells silenced for caspase-2 expression. A. U87MG cells were fixed and processed for
immunofluorescence. Epifluorescence microscopy followed by deconvolution analysis was used to visualize different subcellular compartments
and cholesterol distribution. With arrows indicate LDs and green arrows LDs encircled by lysosomes. Scale bar 40 mM. B. U87MG cells were transfected
with siRNA against caspase-2 or control siRNA as indicated. 48 h later cells fixed and stained with filipin to visualize the intracellular distribution of
cholesterol. Arrows point to LDs. Scale bar 30 mM. C. Quantitative analysis of LDs presence in U87MG and IMR90-E1A cells transfected with siRNA
against caspase-2 or control siRNA. Data are presented as mean 6 SD; n= 3.
doi:10.1371/journal.pone.0110610.g002
Figure 3. Analysis of LIPA and caspases expression in GBM and different areas of the CNS. A. Plot of CASP2 versus LIPA expression levels
in GBM. Linear regression is reported. B. Correlations in expression levels between LIPA and the indicated genes in GBM. C. Correlations in expression
levels between LIPA and the indicated genes in different CNS areas.
doi:10.1371/journal.pone.0110610.g003
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LIPA generates unesterified cholesterol, which can be used as
substrate for steroidogenesis or be re-esterified for storage in lipid
droplets by acyl-CoA:cholesterol acyl transferase [32]. The
increase of LIPA levels in cells with down-regulated caspase-2
might compensate a deficit in Srebp2-driven lipid synthesis/
accumulation in human cells, as previously suggested [29].
To understand whether mRNA levels of LIPA, CYP51A1 and
CYP1B1 are influenced by other caspases, we silenced caspase-8
expression in U87MG cells. We selected caspase-8 because, like
caspase-2, it is a regulative apoptotic caspase, and because it is
expressed in U87MG cells (Figure S1A). The designed siRNA
silenced caspase-8 expression (Figure S1B). When Caspase-8
expression was down-regulated only CYP1B1 mRNA levels were
clearly augmented. LIPA and CYP51A1 expression was not
significantly changed.
Analysis of intracellular cholesterol distribution in
caspase-2 silenced cells
Having evidences of the existence of a connection linking
caspase-2 to some genes of the cholesterol pathway, we compared
the subcellular distribution of cholesterol after labeling of IMR90-
E1A and U87MG cells with filipin. Fluorescence staining was
detectable in the plasma membrane (PM) and in intracellular
membrane structures (Fig 2A). As expected co-localization studies
using GM130, transferrin receptor and LBPA, as markers
respectively of, Golgi apparatus, late endosomal compartment
and endosomal/recycling compartment evidenced that cholesterol
can be detected in all these organelles. In addition, intense filipin
fluorescence staining was present in regular spherical structures
that do not co-localize with the used markers and that can be
identified as LDs (lipid droplets).
Next we compared filipin staining between caspase-2 silenced
and control cells. Remarkably, the number of LDs detectable in a
cell, as well as the percentage of cells holding them was reduced
after caspase-2 silencing (Fig. 2B). Quantitative analysis proved
that in both cell lines, the percentage of cells presenting LDs was
reduced after caspase-2 silencing (Fig. 2C). This observation
further indicates that down-regulation of caspase-2 could influence
in cholesterol homeostasis.
Correlation studies of LIPA and caspase-2 expression in
glioblastoma
Taking into account the complex regulative networks influenc-
ing cholesterol homeostasis in vivo, the use of the cell culture
models to investigate correlations between caspase-2 and choles-
terol genes expression is limiting. Hence, to further expand our
study we decided to interrogate public available gene expression
datasets of glioblastomas. In principle, if caspase-2 controls a
circuit that influence LIPA expression in cultured glioblastoma
cells the expression of these two genes should be inversely
correlated in tumors. Gene expression profiles from 13 datasets
including 327 microarrays of GBM were interrogated. Figure 3A
illustrates that in glioblastoma, mRNA levels for CASP2 and LIPA
evidence a weak, but significant inverse Pearson correlation (r -
0.2593; p-value 2.00E-00.6).
Since also caspase-8 down-regulation can influence the expres-
sion of certain cholesterol genes (Figure S1), we extended this study
to all caspases. as well as, to elements of the molecular platform
involved in caspase-2 activation (CRADD/RAIDD and PIDD)
[8,9]. With the exclusion of CASP1 mRNA, which level weakly
but positively correlates with LIPA, all the other caspases do not
evidence significant correlations with LIPA expression (Fig. 3B).
Concerning PIDD, its expression negatively correlates with LIPA
mRNA levels (r -0.3497; p-value 3.38E-014) in GBM.
Expression correlations between CASP2/LIPA and PIDD/
LIPA were also evaluated in normal tissues. A good and significant
inverse correlation was scored for both genes in cerebellum. On
the contrary, in the hippocampus and with lowest score in the
brain, a significant positive correlation only for CASP2/LIPA was
observed (Fig. 3C). Interestingly, differences in terms of expression
of cholesterol genes between different brain areas are known [35].
Expression correlations among caspases and cholesterol
genes in normal brain and in glioblastoma
Although in cultured cell lines we noted an inverse correlation
in terms of expression between CASP2 and LIPA, in vivo the
situation is heterogeneous, as suggested by the analysis of different
CNS (Central Nervous System) areas. Moreover, since silencing of
caspase-2 affects also other cholesterol genes, it is evident that
these correlations cannot be simply analyzed without taking into
account other genes involved in cholesterol homeostasis. For
example down-regulation of LIPA provoked the up-regulation of
several genes implicated in cholesterol biosynthesis, as compensa-
tory mechanism [36]. Therefore, we decided to investigate with a
more comprehensive approach the correlations between expres-
sion of caspase-2 and the expression of genes involved in
cholesterol homeostasis. We extended this study to all caspases
and we also included the normal tissues. Gene expression profile
data from 11 datasets including 293 microarrays of normal brain
were recovered from public available databases.
We first evaluated changes in the mRNA levels for the different
caspases between normal brain and GBM. Surprisingly the
mRNA levels of several caspases, both inflammatory (CASP1
and CASP4) and apoptotic (CASP3, CASP6, CASP7 and CASP8)
were significantly augmented in tumor samples (Fig. 4A).
Next, genes involved in cholesterol homeostasis, including
steroidogenesis were extracted from Gene Ontology (GO) and
integrated from literature data. In total we selected 256 genes, of
which 166 were grouped into 5 categories: biosynthesis, adsorption/
import, export, steroid and bile acid synthesis and transcriptional
regulators. The category export was subdivided into HDL (High
Density Lipoproteins), LDL (Low Density Lipoproteins) and
VLDL (Very Low Density Lipoproteins). At this point we
exploited microarray datasets to evaluate correlations in the
expression levels between caspases and cholesterol genes. Pearson
correlation between the expression level of each caspase and each
cholesterol gene was computed for human brain samples. Based
on the similarity in correlation patterns caspases and cholesterol
genes were hierarchically clustered using the complete linkage
method.
Figure 4. Co-expression analysis of caspases and cholesterol genes in human brain and GBM. A. Expression levels of the different
caspases in GBM and in the normal brains. Box plots depicted in red mark tumors whereas blue was used for normal brain. mRNA levels of CASP1,
CASP3, CASP4, CASP6, CASP7 and CASP8 were significantly augmented in tumor samples. p-value ,2.2e-16. B. Correlations of expression levels
between caspases and cholesterol genes in different brain and GBM samples in Cholesterol export, lipoproteins category. Data obtained were used to
calculate the correlation values with the Pearson method. In the heat map positive values are displayed in blue and negative in dark green. The
dendrograms displayed on the top are based on hierarchical clustering using the complete linkage method.
doi:10.1371/journal.pone.0110610.g004
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Cholesterol export, lipoproteins. The CNS produces its
own lipoprotein transport system that is distinct from the plasma
[37]. CASP1, 2, 8, 9, and 10 share correlations in terms of changes
in the mRNA levels with several genes involved in HDL
biogenesis. In particular expression of CASP2, 9 and 10 show
the highest correlations with APOD, APOM, APOE, APOA5,
PON1, CAV1, CAV3, ABCA1 and ABCG1 (Fig. 4B and Table
S2).
APOD and APOM are apolipoprotein belonging to the
lipocalin protein superfamily [38]. APOM expression is under
the influence of hormones and cytokines [39]. In apoM-deficient
mice plasma HDL are reduced by approximately 17–21% [40].
Moreover, APOM is an important carrier of shingosine-1-
phosphate (S1P), a signaling molecule controlling several processes
including inflammation [41]. APOD not only contributes to HDL
formation but can also act as antioxidant [42]. This function could
explain the up-regulation of APOD expression with aging in
human prefrontal cortex, as part of a protective circuit [38,43].
APOE is the major apolipoprotein for CNS HDL and is mainly
synthetized by astrocytes [37,44]. It is possible that ApoE-
containing lipoproteins are involved in delivering cholesterol to
neurons for growth, repair and synaptogenesis [37,45]. Fluctua-
tions in APOE mRNA could be related to repair. In fact, in
astrocytes ApoE synthesis increases dramatically after nerve injury
[46,47]. APOE and in particular the e4 allele is the major known
genetic risk factor for late-onset Alzheimer’s disease [48].
PON1 belongs to paraoxonase genes family and is secreted into
the extracellular environment where it binds HDL. This
antioxidant enzyme confers to HDL some of the anti-atherogenic
properties, such as HDL-mediated cholesterol efflux from
macrophages, and the inhibition of LDL oxidation [49].
Although in the brain their activities are less characterized,
ATP-binding cassette (ABC) transporters ABCA1 and ABCG1,
but also CAV1 and CAV3 mediate cholesterol efflux and play
important roles in the transfer of phospholipids and cholesterol to
apolipoproteins such as ApoE and ApoM [37,50].
In GBM expression correlations among constituents of HDL
and pro-apoptotic regulative CASP2, 8, 9, and 10 are still present
but reduced. In particular CASP2, 9 and 10 do not show
significant correlations with APOD, ABAC1 and CAV1 and also
in the case of ABCG1 the correlation is diminished. Instead,
another transporter, ABCG4 exhibits correlations.
In GBM, CASP1 reveals profound different correlations with
HDL genes and clusters together with CASP4, another inflam-
matory caspase, and the effector caspases. HDL genes showing
strongest correlations with CASP1 are APOL1, SOAT1, CAV1,
ABCA1 and PCTP. Interestingly, cholesterol efflux associates
more strongly with the expression of ABCG1 than of ABCA1 [51].
Cholesterol biosynthesis. Almost all the cholesterol found
in the CNS is produced from local biosynthesis [52]. Also in the
case of the category ‘‘cholesterol biosynthesis’’, correlation analysis
revealed that the regulative apoptotic caspases, with the addition
of CASP1 cluster together. In particular strong positive correla-
tions (Fig. 5 and Table S3) with mRNA levels of a group of genes
involved in cholesterol biosynthesis (LSS, CYB5R3, DHCR7,
MVK) emerged. By contrast, HMGCR the gene encoding for the
enzyme converting the 3-hydroxyl-3-methyl-glutarylCoA (HMG-
CoA) into mevalonate scores a good but negative correlation.
Since it represents the limiting step in cholesterol biosynthesis, the
implications of the correlations between certain enzymes of
cholesterol biosynthesis and regulative apoptotic caspases are
unclear at the moment. Significant correlations were not observed
for all the other caspases. Expression of CYP51A1 in the brain
achieves a strong inverse correlation compared to CASP2, CASP9
and CASP10. CYP51A1 encodes for lanosterol 14a-demethylase,
which in addition to being a key enzyme of the cholesterol
biosynthetic pathway [31] is also involved in the steroidogenesis
[53].
In GBM correlations among regulative apoptotic caspases and
genes involved in cholesterol biosynthesis are less evident. Again
CASP1 clustered with effector caspases in the absence of
significant correlation scores. Interestingly, CASP3 shows good
correlations with some genes involved in cholesterol biosynthesis
including HMGCR.
Cholesterol absorption/import. Lipoproteins produced by
astrocytes can be internalized, after binding to LDL receptor
superfamily by neurons and glia cells [37]. Also in the category of
absorption/import, analysis of the correlations at mRNA levels
resulted in two clusters where the regulative apoptotic caspases
plus CASP1 segregate from all the others. CASP2 CASP9 and
CASP10 show the strongest correlations with APLP2, LRP1,
LDLR, LRP2, LRP5, MSR1, LIPG, SCARF1, GPIHBP1, NPC2,
LAMTOR1 and LDLRAP1 (Fig. 5 and Table S4).
LDLR, LRP1, LRP2, LRP5 are all members of the low-density
lipoprotein receptors family [54]. These receptors can bind a large
number of extracellular ligands but a common ligand for all is the
ApoE protein, which mediates internalization and catabolism of
lipoprotein particles [55]. The LDLR is highest expressed in glial
cells than in neurons, on the opposite LRP1 is highest expressed in
neurons than in glia [56,57]. These observations suggest that
correlations with regulative apoptotic caspases are not limited to a
specific cell type. APLP2 an APP homologous can influence LRP1
expression and the toxicity mediated by beta-amyloid oligomers
[58]. LDLRAP1 encodes for an adaptor cytosolic protein that
interacts with and is involved in the endocytosis of LDLR. MSR1,
SCARF1 and SCARB1 are involved in the uptake of lipoproteins.
Endothelial lipase (LIPG) regulates the circulating level of HDL
[59]. It is expressed in different areas of the CNS including CA3
pyramidal cells of the hippocampus, ependymal cells in the ventral
part of the third ventricle [60]. LIPG is also expressed in brain
capillary endothelial cells, major constituents of the blood brain
barrier [61]. GPIHBP1, (glycosylphosphatidylinositol-anchored
high-density lipoprotein binding) can be considered a platform
for lipolysis [62] and it is also involved in the transport of
lipoprotein lipase (LPL) [63]. LAMTOR1 and NPC2 work
downstream to the internalization of lipoproteins. The first as
key regulator of endosome dynamics and lysosome biogenesis, the
second by removing unesterified cholesterol from late endosomes/
lysosomes [64,65].
It is evident that several genes involved in cholesterol and lipids
up-take show a coordinate expression with regulative apoptotic
caspases. High positive scores in terms of correlation among pro-
apoptotic regulative caspases and genes involved in cholesterol
internalization are in agreement with the negative score observed
in the case HMGCR [66]. In GBM, as above observed for other
categories, these correlations are less robust and CASP1 distinctly
Figure 5. Co-expression analysis of caspases and cholesterol genes in human brain and GBM. Correlations in terms of expression levels
between caspases and cholesterol genes in different brain and GBM samples, for the indicated categories. Data obtained were used to calculate the
correlation values with the Pearson method. In the heat map positive values are displayed in blue and negative in dark green. The dendrograms
displayed on the top are based on hierarchical clustering using the complete linkage method.
doi:10.1371/journal.pone.0110610.g005
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changes relationships with cholesterol genes, thus clustering with
the effector caspases.
Steroid and bile acid synthesis. This category collects
heterogeneous gene families. Nevertheless, the apoptotic regulative
caspases cluster again together, whereas CASP1 is here found
together with other inflammatory caspases and with the effector
caspases. TSPO, CYP7B1, CYP8B1 and CYP19A1 show the
highest positive correlation scores (Fig. 6 and Table S5).
Steroid biosynthesis begins with the transfer of free cholesterol
from intracellular stores into mitochondria [67]. TSPO encodes
for a translocator located on the outer mitochondrial membrane,
which binds cholesterol with high affinity and transfers it in the
inner mitochondrial membrane. TSPO activity is the rate-limiting
step in the synthesis of all steroids [68]. Interestingly, alterations in
TSPO expression has been found in various psychiatric disorders,
including social phobia, post-traumatic stress disorder, adult
separation anxiety and schizophrenia [69].
CYP7B1 catalyzes 7-hydroxylation of C19 and C21 steroids and
in the brain it is involved in the metabolism of neurosteroids and
oxysterols [70]. Defects of CYP7B1 in humans have been linked to
spastic paraplegia [71,72].
CYP8B1 is a sterol 12a–hydroxylase. In mice expression of
CYP7A1 and of CYP8B1 is integrated [73]. In the liver, circadian
signals can influence CYP7A, CYP8B, and CYP51A1 expression
[74].
CYP19A1 encodes for the cytochrome P450 aromatase an
enzyme responsible for the synthesis of all oestrogens from
androgen precursors [75]. Oestradiol synthesis in the brain
regulates several functions of the adult CNS, from neural plasticity
to injury responses [76]. Increased expression of CYP19A1 during
neurodegeneration could interfere with apoptotic pathways and to
decrease the extent of brain damage [77].
In glioblastoma the correlations affect other genes and are in
general attenuated. TSPO expression is not longer linked to
regulative caspases, whereas it shows positive correlations with
effectors and inflammatory caspases.
Transcriptional regulators. Finally, we investigated the
correlations among caspases and the expression of TFs (Tram-
scription Factors) involved in the control of cholesterol genes
expression. Figure 6 documents the results, which photocopy those
previously obtained with the other categories. Apoptotic regulative
caspases and CASP1 share similar relationships, in terms of
expression correlations, with transcriptional regulators of choles-
terol genes. SREBF1, SREBF2, PPARA and NR1H2 display the
highest score with CASP2, CASP9 and CASP10 (Figure 6 and
Table S6). In the case of SREBF2, Pearson correlation coefficients
with caspases were similar to those described for cholesterol genes
[78].
SREBF1 and SREBF2 (sterol regulatory element binding
proteins) are TFs that control cellular lipid homeostasis. SREBF1
encodes for two proteins Srebp1a and Srebp1c produced via
alternative transcription start sites. Srebp1c preferentially influ-
ences expression of fatty acid biosynthesis genes, whereas Srebp2 is
devoted to transcribe genes involved in cholesterol homeostasis,
lipoproteins import and lipids trafficking. Serbp1a can support
transcription of both SREBF1 and SREBF2 genes [79]. In this
respect it is interesting to note that only SREBF2 accomplishes a
good correlation with CASP2 in GBM.
PPARA belongs to the family of peroxisome proliferator-
activated receptors, which includes (PPARa, PPARb/d and
PPARc). These TFs function as obligate heterodimers with
retinoid-X receptors (RXRs). PPARa supervises energy homeo-
stasis by stimulating fatty acids and cholesterol breakdown and
gluconeogenesis [80–82]. PPARb/d is mainly engaged in fatty
acid oxidation. PPARc principal activity is to drive storage of
lipids, in particular by controlling adipocyte differentiation [83]. In
the brain PPARD is the most abundant and quite ubiquitously
expressed member, whereas PPARA and PPARG are expressed in
more restricted areas and cell types [84,85]. In addition to their
metabolic role, PPARs in the CNS have been implicated in the
control of neuronal differentiation, death, inflammation and
neurodegeneration [83]. In GBM expression correlation between
PPARA and regulative caspases are abrogated. On the other side a
good correlation between PPARG and CASP1 appears (Fig. 6).
NR1H2 (liver X receptor-beta) is another master TF orches-
trating the expression of genes of the cholesterol homeostasis [86].
Similarly to SREBF1, SREBF2 and PPARA correlations between
NR1H2 and CASP2, CASP9 and CASP10 are abrogated in
GBM. Interestingly, in GBM new correlations emerged between
the second nuclear hormone receptors liver X receptor alpha
(LXRalpha/NR1H3) and inflammatory caspases CASP1 and
CASP4.
In summary, the correlation among regulative apoptotic
caspases and certain cholesterol genes observed in this study
could be orchestrated by selected TFs, well-known master
regulators of cholesterol metabolism such as SREBF1, SREBF2,
PPARA and NR1H2.
Expression correlations among caspases and cholesterol
genes in the liver
To understand whether our discoveries are limited to CNS or
can be observed also in other tissues, we decided to compare
variations in the expression levels of caspases and of cholesterol
genes in human liver, an essential organ for cholesterol homeo-
stasis. Gene expression profiles from 5 datasets including 106
microarrays of normal human liver were interrogated. Figure 7
shows that correlations among cholesterol genes and expression of
regulative apoptotic caspases are less pronounced and only in
some categories: transcriptional regulators, cholesterol biosynthesis,
steroid and bile acid synthesis, these genes cluster together. In the
liver CASP7 reaches the highest scores both for positive and
negative correlations. For example CASP7 expression is strongly
inversely correlated with those of several apolipoprotein genes, but
it positively correlates with NPC1, VLDLR, SOAT1, SNX17 and
VPS4B (Table S7); which are genes involved in cholesterol up-take
and storage. It is important to note that similarly to caspase-2,
caspase-7 expression is under the influence of Srebp1/2 and of
statins [87].
CASP9 and CASP10 in terms of correlations with cholesterol
genes maintain in the liver a pattern resembling that remarked in
the brain and they cluster in almost all categories. By contrast
CASP2 exhibits a correlation pattern rather different from the
brain and it frequently clusters with CASP5. This observation
suggests that the correlations between caspase-2 and cholesterol
genes are related to a specific brain endeavor [88,89]. Remark-
Figure 6. Co-expression analysis of caspases and cholesterol genes in human brain and GBM. Correlations of expression levels between
caspases and cholesterol genes in different brain and GBM samples, for the indicated categories. Data obtained were used to calculate the correlation
values with the Pearson method. In the heat map positive values are displayed in blue and negative in dark green. The dendrograms displayed on the
top are based on hierarchical clustering using the complete linkage method.
doi:10.1371/journal.pone.0110610.g006
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ably, several reports have proposed specific biological activities for
caspase-2 in the CNS [26,89–91].
Caspases, cholesterol genes and aging
Changes in the expression of cholesterol genes in the brain are
linked to several physiological/pathological conditions including,
regeneration, plasticity, circadian rhythms, diet, degeneration,
social behavior and also the presence of several different cell
linages [37,38,43,58,69,74,77,83,92]. To understand the signifi-
cance of the described correlations, we decided to interrogate
more precisely the public available datasets used in our studies. We
restricted our inquiries to one dataset (GSE 17612) in which,
information about the specific brain area (the anterior prefrontal
cortex/Brodmann area 10) and subjects age were available. 23
microarray of normal brain met these requirements. Age
distribution is shown in figure 8A. Cholesterol and caspase genes
were ranked accordingly to the Spearman method, respect to the
age of the subjects. Figure 8B illustrates that the expression of a set
of cholesterol genes shows a good inverse correlation respect to age
(green dots) and on the opposite, the expression of a different set of
genes increases with aging (blue dots).
Among genes, which mRNAs levels are down-regulated with
aging, we have found CYP46A1 and HMGCR (Fig. 8B and 8C).
CYP46A1 encodes for the hydroxylase, which converts cholesterol
to 24S-hydroxycholesterol and provides the major route in
cholesterol excretion from the brain [93]. In the case of HMGCR
our observations are in agreement with previous results pointing to
a decline in brain cholesterol synthesis with age [43,94,95]. On the
opposite previous study reported an up-regulation of cholesterol-
24-hydroxylase mRNA in mouse brain with aging [96]. Indeed in
their studies the authors analyzed the hippocampus from day 10
up to 21 months. After an up-regulation at 3 months, a trend to
decrease in both mRNA and protein levels of CYP46A1 can be
appreciated. In humans 24S-hydroxycholesterol levels are highest
in the first decade of life and then decline with age [97].
Furthermore, also in human brain, analysis of cholesterol 24-
hydroxylase protein evidenced some reduction during aging [98].
Undoubtedly, further studies are necessary to clarify this point.
Taking into account that mice lacking 24-hydroxylase exhibit
severe learning and memory defects [99], clarification of
CYP46A1 expression during aging is of particular interest.
We have included in this analysis also the different caspases.
Figure 8C reveals that expression of inflammatory CASP1 and
also of the effector caspases CASP6 and CASP7 positively
correlates with aging.
Several studies have indicated a contribution of caspase-6 to
neurodegeneration including Alzheimer and Huntington diseases
[100–104]. A more recent report has proposed that caspase-6
activity can predict lower episodic memory ability in aged
individuals [105]. CASP1 is a key regulator of inflammation, via
the generation of IL-1b and involved in the regulation of age-
related cognitive-dysfunctions. CASP1 genetic variations have
been associated with cognitive function [106] and several data
have linked caspase-1 to brain aging [107,108]. Deficiency in
Nlrp3 inflammasome-mediated caspase-1 activity improved cog-
nitive function and motor performance in aged mice [109].
Furthermore, caspase-1 also influences in a still undetermined
manner lipid metabolism [110].
Conclusions
Our initial aim, of discovering compensatory pathways to solve
the caspase-2 mystery has led us to unveil large and shared
correlations among different caspases and cholesterol genes.
Expression correlations studies have attracted attention to uncover
new biological circuits [111,112] and dedicated methodological
tools have been developed [113,114]. We have applied hierarchi-
cal clustering of gene expression correlations to hypothesize new
functions for caspases and caspase-2 in particular. An unexpected
finding was that the regulative apoptotic caspases (CASP9 and
CASP10 in particular) share a correlation pattern with cholesterol
genes, similarly to CASP2. The reported strong correlations
among these caspases and certain cholesterol genes in a
heterogeneous tissue, such as the human brain and in a
heterogeneous population, suggest that expression of these genes
is influenced by common signaling networks linked to specific
biological processes. Hence, expression of certain cholesterol genes
and of regulative apoptotic caspases in the brain should be under
the control of the same regulative circuits. Since in GBM these
correlations are in general less prominent, it is possible that genetic
lesions, altering proliferation also impact on cholesterol homeo-
stasis. Although the contribution of cholesterol genes to GBM
development is largely unexplored, recently a survival pathway
engaged by the LDL receptor, through the EGFRvIII/PI3K/
SREBP-1 axis has been discovered [115]. This observation
suggests that oncogenic driven changes in gene expression could
revise the harmonic co-regulation of caspases and cholesterol
genes.
This scenario is well exemplified by CASP1, which evidences
the most overt changes in terms of correlations with cholesterol
genes between brain and GBM. Taking into account that its
expression is augmented in GBM, these changes could reflect the
establishment of an inflammatory microenvironment.
When the same analysis were performed using microarray data
obtained from cultured glioblastoma cells, correlations were in
general weaker and apoptotic regulative caspases clustered
separately (data not shown). This observation indicates that
complex networks of environmental signals control the expression
of these genes. Networks that cannot be easily replaced under in
vitro culture conditions. A consideration that could explain the low
number of genes, which expression is influenced by caspase-2
siRNA in cultured glioblastoma cells.
It is evident that, correlations in terms of expression could
have different biological origins/implications: from the presence
of different cell lineages in the sample, up to different neuronal
activities, different inflammatory/degenerative states, different
cognitive functions and different hormonal signaling. We are
consciousness that this complexity deserves further experimental
work. Here we have discovered that for some caspases, in a
specific brain’s area, the correlations with certain cholesterol
genes could be related to aging. In this case the correlation
could be linked to the induction of degenerative processes. In
fact, caspase signaling engaged by the ordered activation of
caspase-8 and caspase-3/7 controls microglia activation and
neurotoxicity with implications in Parkinson’s and Alzheimer’s
diseases [116].
For other caspases, including caspase-2 the reason for this
correlation is unclear at the moment. Taking into account that
Figure 7. Co-expression analysis of caspases and cholesterol genes in human liver. Correlations of expression levels between caspases and
cholesterol genes in different liver samples, for the indicated categories. Data obtained were used to calculate the correlation values with the Pearson
method. In the heat map positive values are displayed in blue and negative in dark green. The dendrograms displayed on the top are based on
hierarchical clustering using the complete linkage method.
doi:10.1371/journal.pone.0110610.g007
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evidences sustaining non-apoptotic roles of caspases in the CNS
are accumulating [117] several hypothesis concerning caspase-2
could be formulated. Previous studies [28], here confirmed, linking
SREBFs levels to CASP2 expression suggest a direct involvement
of this enzyme in cholesterol homeostasis. Although the mecha-
nisms need to be elucidated, our data further encourage
investigating towards this direction.
Figure 8. Analysis of cholesterol and caspase genes expression with aging in anterior prefrontal cortex. A. Bar plot displaying the age
frequencies of the samples used in the analysis. B. Dot plot of ranked correlations of the 129 genes involved in cholesterol homeostasis/
steroidogenesis and caspases respect to age. C. Dot plot of ranked correlations of genes involved in cholesterol homeostasis/steroidogenesis and
caspases that scored significant expression correlation with respect to age. We applied the Spearman method (Benjamini and Hockberg correction).
P,0.05.
doi:10.1371/journal.pone.0110610.g008
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Supporting Information
Figure S1 A. Expression profiles in U87MG cells of the
different caspases. Microarray expression data were obtained
from GSE14889 [118]. B. mRNA expression levels of CASP8
were measured using qRT-PCR in U87MG cells transfected with
siRNA against Caspase-8 or a control siRNA. Data are presented
as mean 6 SD; n=3. C. mRNA expression levels of CYP1B1,
CYP51A1 and LIPA were measured using qRT-PCR in U87MG
cells transfected with siRNA against Caspase-8 or a control
siRNA. Data are presented as mean 6 SD; n=3.
(JPG)
Table S1 Genes down-regulated.1.5 fold in U87MG
cells silenced for Caspase-2.
(XLS)
Table S2 Top score cholesterol genes of the subclass
cholesterol export in terms of correlations of expression
levels with regulative apoptotic caspases in human
brain. Values are shown for all caspases.
(XLS)
Table S3 Top score cholesterol genes of the subclass
cholesterol biosynthesis in terms of correlations of
expression levels with regulative apoptotic caspases in
human brain. Values are shown for all caspases.
(XLS)
Table S4 Top score cholesterol genes of the subclass
cholesterol adsorption/import in terms of correlations
of expression levels with regulative apoptotic caspases
in human brain. Values are shown for all caspases.
(XLS)
Table S5 Top score cholesterol genes of the subclass
steroid and bile acid synthesis in terms of correlations of
expression levels with regulative apoptotic caspases in
human brain. Values are shown for all caspases.
(XLS)
Table S6 Top score cholesterol genes of the subclass
transcriptional regulators in terms of correlations of
expression levels with regulative apoptotic caspases in
human brain. Values are shown for all caspases.
(XLS)
Table S7 Top score cholesterol genes in terms of
correlations of expression levels with caspase-7 in
human liver. Values are shown for all caspases.
(XLS)
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